Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease worldwide. However, current treatments remain suboptimal. Many factors, such as genetic and nongenetic promoters, hypertension, hyperglycemia, the accumulation of advanced glycation end products (AGEs), dyslipidemia, and albu...
Saved in:
| Main Authors: | Masako Furukawa, Tomohito Gohda, Mitsuo Tanimoto, Yasuhiko Tomino |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/928197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK- Mouse
by: Masako Furukawa, et al.
Published: (2013-01-01) -
Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy
by: Shaimaa I. Barr, et al.
Published: (2025-05-01) -
Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes
by: Liping Wang, et al.
Published: (2025-01-01) -
Research progress in the pathogenesis of diabetic nephropathy
by: LI Jia-xin, et al.
Published: (2019-01-01) -
The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
by: Jian Tang, et al.
Published: (2019-01-01)